AstraZeneca completes the acquisition of Bristol-Myers Squibb share of global diabetes alliance

AstraZeneca announce that it completed, on 1 February 2014, the acquisition of the entirety of Bristol-Myers Squibb’s interests in the companies’ diabetes alliance (AstraZeneca)